NIST trumps the clumps: Making biologic drugs safer

(National Institute of Standards and Technology (NIST)) NIST scientists have developed a technique to measure the formation of clumps of proteins in protein-based pharmaceuticals, a major concern because of its impact on quality control and safety in biologic drug manufacturing.


 

More related items

Candy-coating keeps proteins sweet
(National Institute of Standards and Technology (NIST)) Researchers at NIST have developed a fast, inexpensive and effective method for evaluating...

Improved reaction data heat up the biofuels harvest
(National Institute of Standards and Technology (NIST)) In a new paper, researchers at the National Institute of Standards and Technology have...

Cool! Nanoparticle research points to energy savings
(National Institute of Standards and Technology (NIST)) NIST experiments with varying concentrations of nanoparticle additives indicate a major...

R&D 100 Award for new NIST/UMD neutron detector
(National Institute of Standards and Technology (NIST)) A new ultra-sensitive, high bandwidth neutron detector developed by NIST and the University...

The Design and Construction of Large Optical Telescopes
This book assembles for the first time in a single text the full range of astronomical and engineering principles used in the design and construction...

Textbook of Biochemistry With Clinical Correlations (Textbook...
Thomas M. Devlin's Textbook of Biochemistry with Clinical Correlations presents the biochemistry of mammalian cells, relates events at a cellular...

Molecular Gastronomy: Exploring the Science of Flavor (Arts and...
Hervé This (pronounced "Teess") is an internationally renowned chemist, a popular French television personality, a bestselling cookbook author, a...


 

Post new comment

The content of this field is kept private and will not be shown publicly.
science-nature.marc8.com